WO2015017125A3 - Procédé de traitement du syndrome de barrett et de l'adénocarcinome œsophagien - Google Patents
Procédé de traitement du syndrome de barrett et de l'adénocarcinome œsophagien Download PDFInfo
- Publication number
- WO2015017125A3 WO2015017125A3 PCT/US2014/046702 US2014046702W WO2015017125A3 WO 2015017125 A3 WO2015017125 A3 WO 2015017125A3 US 2014046702 W US2014046702 W US 2014046702W WO 2015017125 A3 WO2015017125 A3 WO 2015017125A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- metaplasia
- methods
- esophageal adenocarcinoma
- barrett
- treating barrett
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
L'invention concerne des procédés de traitement du syndrome de Barrett et de l'adénocarcinome œsophagien et des procédés de détermination d'une charge de mutation en tant que facteur de prévision du risque d'évolution pathologique du syndrome de Barrett en adénocarcinome œsophagien.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/954,247 | 2013-07-30 | ||
US13/954,247 US10131942B2 (en) | 2011-12-01 | 2013-07-30 | Methods for treating barrett's metaplasia and esophageal adenocarcinoma |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2015017125A2 WO2015017125A2 (fr) | 2015-02-05 |
WO2015017125A3 true WO2015017125A3 (fr) | 2015-06-04 |
Family
ID=52432543
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2014/046702 WO2015017125A2 (fr) | 2013-07-30 | 2014-07-15 | Procédé de traitement du syndrome de barrett et de l'adénocarcinome œsophagien |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2015017125A2 (fr) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002088388A1 (fr) * | 2001-04-26 | 2002-11-07 | Ruebben Albert | Procede et dispositif de quantification de charges de mutation |
US20060088874A1 (en) * | 2004-10-22 | 2006-04-27 | Promega Corporation | Methods and kits for detecting mutations |
US20130143222A1 (en) * | 2011-12-01 | 2013-06-06 | RedPath Integrated Pathology, Inc | Methods for treating barrett's metaplasia and esophageal adenocarcinoma |
US20130267426A1 (en) * | 2012-04-10 | 2013-10-10 | Katholieke Universiteit Leuven, K.U. Leuven R&D | Microsatellite instability markers in detection of cancer |
-
2014
- 2014-07-15 WO PCT/US2014/046702 patent/WO2015017125A2/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002088388A1 (fr) * | 2001-04-26 | 2002-11-07 | Ruebben Albert | Procede et dispositif de quantification de charges de mutation |
US20060088874A1 (en) * | 2004-10-22 | 2006-04-27 | Promega Corporation | Methods and kits for detecting mutations |
US20130143222A1 (en) * | 2011-12-01 | 2013-06-06 | RedPath Integrated Pathology, Inc | Methods for treating barrett's metaplasia and esophageal adenocarcinoma |
US20130267426A1 (en) * | 2012-04-10 | 2013-10-10 | Katholieke Universiteit Leuven, K.U. Leuven R&D | Microsatellite instability markers in detection of cancer |
Non-Patent Citations (1)
Title |
---|
ELLSWORTH, E ET AL.: "Correlation Of The Presence And Extent Of Loss Of Heterozygosity Mutations With Histological Classifications Of Barrett's Esophagus.", BMC GASTROENTEROL., vol. 12, no. 181, 27 December 2012 (2012-12-27) * |
Also Published As
Publication number | Publication date |
---|---|
WO2015017125A2 (fr) | 2015-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1245140A1 (zh) | 使用自然殺傷細胞治療血液病症、實體瘤或感染性疾病的方法 | |
GB201716486D0 (en) | Peer to peer attestation | |
EP3370703A4 (fr) | Combinaison de gemcabène pour le traitement de maladies cardiovasculaires | |
EP3122414A4 (fr) | Traitement de maladie veineuse | |
HK1231401A1 (zh) | 治療阿爾茨海默氏病的方法 | |
EP3259592A4 (fr) | Nouvelle stratégie de remodelage cutané | |
EP3259594A4 (fr) | Biomarqueurs de blessure myocardique | |
EP2981252A4 (fr) | Méthodes de traitement de maladies caractérisées par une signalisation wnt excessive | |
EP3125870A4 (fr) | Procédés de traitement de la maladie coeliaque avec le larazotide | |
HK1215173A1 (zh) | 治療金黃色葡萄球菌相關疾病的方法 | |
HK1225732A1 (zh) | 作為rorc調節劑用於治療自身免疫性疾病的5,6,7,8-四氫-5,8-亞甲基噌啉衍生物 | |
WO2015179835A3 (fr) | Biomarqueurs mit et leurs méthodes d'utilisation | |
EP2994134A4 (fr) | Méthodes d'administration de dantrolène dans le traitement d'urgence des arythmies cardiaques | |
EP3169259A4 (fr) | Cryolipolyse cardiaque pour le traitement de l'arythmie cardiaque | |
GB201516692D0 (en) | Private access to HID | |
IN2014DN06738A (fr) | ||
IL275126B (en) | Methods for predicting the progression of Barrett's esophagus | |
EP3346929C0 (fr) | Anse électrochirurgicale | |
EP3235774A4 (fr) | Grue tout-terrain | |
GB2529200B (en) | Improvement to Analysing Physiological Electrograms | |
PH12016501326A1 (en) | (s)-3'-methyl-abscisic acid and esters thereof | |
EP3305185A4 (fr) | Sphygmomanomètre | |
EP3235674A4 (fr) | Grue tout-terrain | |
EP3129789A4 (fr) | Procédés spectroscopiques permettant de détecter l'hémoglobine glyquée | |
EP2991650A4 (fr) | Méthodes de traitement du cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14831640 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 14831640 Country of ref document: EP Kind code of ref document: A2 |